Announcements Trials
Browse Landscape

Phase

Phase 1/2 6Phase 1 6Phase 2 3

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 251Head & Neck 132Thoracic 46Gynecologic 11Tumor-Agnostic 9Breast 8Genitourinary 5Sarcoma 4CNS 3Plasma cell 2Other solid neoplasm 2Other neoplasm 2Dermatologic 2

Conditions

Glioma 1Glioblastoma 1Brain Neoplasms 1

Interventions

Temozolomide 258Radiotherapy 147Bevacizumab 141Etoposide 68Cyclophosphamide 68Carboplatin 66Magnetic Resonance Spectroscopy 58Irinotecan 53Cisplatin 52Vincristine 45Filgrastim 43pembrolizumab 40Radiosurgery 36Nivolumab 36Radiation 34Topotecan 31Doxorubicin 30Specimen Handling 29sargramostim 28Lomustine 27Erlotinib Hydrochloride 27Peripheral Blood Stem Cell Transplantation 25Carmustine 25Thiotepa 24Everolimus 23Chemotherapy, Adjuvant 23Surgical Procedures, Operative 22Isotretinoin 22Ipilimumab 22Melphalan 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Cetuximab × CNS × Clear all
NCT01012609 2022-03-14

External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adults With Newly Diagnosed Diffuse Pontine Tumors and High-Grade Astrocytomas

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
47 enrolled 18 charts
CNS

Brain Neoplasms

NCT01044225 2012-03-22

Effect of Radiation Therapy Plus Temozolomide Combined With Cilengitide or Cetuximab on the 1-year Overall Survival of Patients With Newly Diagnosed MGMT-promoter Unmethylated Glioblastoma

Universitair Ziekenhuis Brussel

Phase 2 Terminated
12 enrolled
CNS

Glioblastoma

NCT00463073 2008-12-11

Cetuximab, Bevacizumab and Irinotecan for Patients With Malignant Glioblastomas

Rigshospitalet, Denmark

Phase 2 Completed
32 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡